BioLED lab-on-chip technology to be demonstrated at Imperial College,
21 February 2007
Geneva, Switzerland. Acrongenomics, Inc. (OTCBB:AGNM) and Molecular Vision,
Ltd (MVL) have announced that a demonstration version of the BioLED Lab On A
Chip platform combining MVL’s expertise in microfluidics, organic
semiconductor diodes and photodetectors will be presented to a selected
audience at Imperial College’s Bioincubator building, where MVL is situated,
on the 8th of March 2007.
“This is a great achievement for Acrongenomics,” said Mr. Plato
Tzouvalis, President and COO of Acrongenomics. “Our strong support of MLV’s
innovative technology through our joint venture agreement has taken BioLED
technology from concept to the realization of a working demonstrator.”
Molecular Vision is a spin-out company of Imperial Innovations Ltd, which
was founded by three Imperial College London researchers, Prof. Donal
Bradley, Prof. Andrew de Mello and Dr. John de Mello in 2002. Its aim is to
meet the demand in the medical diagnostics, biosensors and analytical
instrumentations markets for miniaturized chemical and biological detectors
offering high sensitivity and functionality at low cost.
The company has invented a novel method for optical detection based on
recent advances in organic electronics and light emitting diodes combined
with microfluidics technology. Molecular Vision recently signed a major
development contract with Acrongenomics Inc. to jointly exploit and
commercialise the technology.